Gaucher disease type 1: Revised recommendations on evaluations and monitoring for adult patients
To access this article, please choose from the options below
Supported in part by a grant from Genzyme Corporation, Cambridge, MA. The Gaucher Registry is sponsored by Genzyme Corporation.
PII: S0037-1963(04)00134-9
doi:10.1053/j.seminhematol.2004.07.010
© 2004 Elsevier Inc. All rights reserved.
Refers to erratum:
- Erratum
